Features Stanford, Schatzberg, and Corcept Therapeutics drbernardcarroll_309 July 9, 2008 Stanford’s account of Dr. Schatzberg’s arm’s-length role in Stanford’s NIH-supported studies of RU 486 (mifepristone) for depression is questionable, if not disingenuous.
